Doceree, a global network of physicians-only platforms for programmatic messaging, on Tuesday said it has raised $35 million in a Series B funding round led by Indian homegrown private equity fund Creaegis.
The new funds will be used by Doceree to accelerate product development, augment technologies, scale global expansion, and expand its team.
Existing investors Eight Roads Ventures and F-Prime Capital also participated in the round.
Founded in 2019 by Jain, Doceree facilitates messaging between life sciences brands and healthcare professionals (HCPs) through a global network of digital endemic and point-of-care platforms to programmatically deliver at scale accurate and transparent messages to HCPs.
“The pharma messaging space is evolving at a fast pace and our solutions are aligned to meet the immediate requirements of the life sciences industry,” said Harshit Jain, founder and global CEO of Doceree.
In 2022, Doceree raised $11 million in its Series A funding round led by Eight Roads Ventures, a global investment firm backed by Fidelity.
Doceree said it has grown more than 100% in the last year, with monthly revenue rising fivefold between the Series A funding in April 2022 and now.
Last week, Creaegis closed its maiden fund at about $425 million from institutional investors, including International Finance Corporation (IFC) and family offices from India, the US, Europe, and Asia.
